NASDAQ: GHIXGores Holdings Ix Inc Stock
$10.59+0.00 (+0%)
Updated Oct 3, 2024
GHIX Price
$10.59
Fair Value Price
$0.02
Market Cap
$202.85M
52 Week Low
$10.38
52 Week High
$11.14
P/E
-34.16x
P/B
-7.1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$14.66M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.1
Operating Cash Flow
-$2M
Beta
-0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
GHIX Overview
Gores Holdings IX, Inc. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets industrials and companies in the tech, telecommunications, media and entertainment, business services, healthcare, and consumer products sectors. Gores Holdings IX was incorporated in 2021 and is based in Boulder, CO.
Zen Score
–
Industry Average (5)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GHIX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GHIX ($10.59) is overvalued by 58,177.13% relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
GHIX ($10.59) is not significantly undervalued (58,177.13%) relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
GHIX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GHIX due diligence checks available for Premium users.
Be the first to know about important GHIX news, forecast changes, insider trades & much more!
GHIX News
Valuation
GHIX fair value
Fair Value of GHIX stock based on Discounted Cash Flow (DCF)
Price
$10.59
Fair Value
$0.02
Overvalued by
58,177.13%
GHIX ($10.59) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GHIX ($10.59) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GHIX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
GHIX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-34.16x
Industry
6.03x
Market
26.22x
GHIX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.1x
Industry
-20.33x
GHIX's financial health
Profit margin
Revenue
$0.0
Net Income
-$5.2M
Profit Margin
0%
GHIX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$65.7M
Liabilities
$31.5M
Debt to equity
-1.1
GHIX's short-term liabilities ($4.07M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GHIX's long-term liabilities ($27.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GHIX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GHIX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.2M
Investing
-$492.4M
Financing
$492.4M
GHIX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
GHIX vs Shell Company Stocks
Gores Holdings Ix Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.